GSTRX
Price
$8.48
Change
+$0.26 (+3.16%)
Updated
Apr 24 closing price
Net Assets
167.32M
VIGRX
Price
$191.08
Change
+$5.47 (+2.95%)
Updated
Apr 24 closing price
Net Assets
260.76B
Ad is loading...

GSTRX vs VIGRX

Header iconGSTRX vs VIGRX Comparison
Open Charts GSTRX vs VIGRXBanner chart's image
Goldman Sachs Strategic Growth R
Price$8.48
Change+$0.26 (+3.16%)
VolumeN/A
Net Assets167.32M
Vanguard Growth Index Investor
Price$191.08
Change+$5.47 (+2.95%)
VolumeN/A
Net Assets260.76B
GSTRX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSTRX vs. VIGRX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSTRX is a Buy and VIGRX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 261B vs. GSTRX (167M). VIGRX pays higher dividends than GSTRX: VIGRX (0.39) vs GSTRX (0.00). GSTRX was incepted earlier than VIGRX: GSTRX (16 years) vs VIGRX (33 years). GSTRX (1.57) is less costly to investors than VIGRX (0.17). GSTRX is a more actively managed with annual turnover of: 39.00 vs. VIGRX (5.00). GSTRX has a lower initial minimum investment than VIGRX: GSTRX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 8.89 vs. GSTRX (0.00). VIGRX return over 5 years is better than : 105.69 vs. GSTRX (5.25).
GSTRXVIGRXGSTRX / VIGRX
Total Expense Ratio1.280.17753%
Annual Report Gross Expense Ratio1.570.17924%
Fund Existence16 years33 years-
Gain YTD-13.291-12.154109%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets167M261B0%
Annual Yield % from dividends0.000.39-
Returns for 1 year0.008.89-
Returns for 3 years-0.2437.20-1%
Returns for 5 years5.25105.695%
Returns for 10 years-33.84230.06-15%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.370.11
+4.87%
Larimar Therapeutics
BH226.993.47
+1.55%
Biglari Holdings
BSY43.900.48
+1.11%
Bentley Systems
TSBX0.32N/A
+0.82%
Turnstone Biologics Corp
VKTX25.66-0.13
-0.50%
Viking Therapeutics